BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12007019)

  • 1. Utility of WT1 as a reliable tool for the detection of minimal residual disease in children with leukemia.
    Kletzel M; Olzewski M; Huang W; Chou PM
    Pediatr Dev Pathol; 2002; 5(3):269-75. PubMed ID: 12007019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia.
    Inoue K; Sugiyama H; Ogawa H; Nakagawa M; Yamagami T; Miwa H; Kita K; Hiraoka A; Masaoka T; Nasu K
    Blood; 1994 Nov; 84(9):3071-9. PubMed ID: 7949179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of dynamic detection of WT1 expression on monitoring minimal residual disease in leukemia patients following allogeneic bone marrow transplantation].
    Gu WY; Chen ZX; Hu SY; Zhu J; Wang ZL; Yan F; Wang W; Cen JN; Shen HL; Qian J
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):444-7. PubMed ID: 15854547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels.
    Inoue K; Ogawa H; Yamagami T; Soma T; Tani Y; Tatekawa T; Oji Y; Tamaki H; Kyo T; Dohy H; Hiraoka A; Masaoka T; Kishimoto T; Sugiyama H
    Blood; 1996 Sep; 88(6):2267-78. PubMed ID: 8822948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sectional monitoring of Wilms' tumor gene 1 (WT1) expression in Iranian patients with acute lymphoblastic leukemia at diagnosis, relapse and remission.
    Asgarian Omran H; Shabani M; Vossough P; Sharifian R; Tabrizi M; Khoshnoodi J; Jeddi-Tehrani M; Rabbani H; Shokri F
    Leuk Lymphoma; 2008 Feb; 49(2):281-90. PubMed ID: 18231915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wilms' tumor gene 1 transcript levels in leukapheresis of peripheral blood hematopoietic cells predict relapse risk in patients autografted for acute myeloid leukemia.
    Messina C; Candoni A; Carrabba MG; Tresoldi C; Sala E; Tassara M; Crippa A; Peccatori J; Assanelli A; Gattillo S; Bellio L; Fanin R; Ciceri F; Bernardi M
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1586-91. PubMed ID: 24954546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.
    Boublikova L; Kalinova M; Ryan J; Quinn F; O'Marcaigh A; Smith O; Browne P; Stary J; McCann SR; Trka J; Lawler M
    Leukemia; 2006 Feb; 20(2):254-63. PubMed ID: 16341043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor correlation of kinetics between BCR-ABL and WT1 transcript levels after allogeneic stem cell transplantation.
    Uzunel M; Ringdén O
    Bone Marrow Transplant; 2004 Jan; 33(1):47-52. PubMed ID: 14704656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wilms tumor gene (WT1) expression as a panleukemic marker.
    Menssen HD; Siehl JM; Thiel E
    Int J Hematol; 2002 Aug; 76(2):103-9. PubMed ID: 12215007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of minimal residual disease (MRD) monitoring by WT1 quantification between childhood acute myeloid leukemia and acute lymphoblastic leukemia.
    Zhang R; Yang JY; Sun HQ; Jia H; Liao J; Shi YJ; Li G
    Eur Rev Med Pharmacol Sci; 2015; 19(14):2679-88. PubMed ID: 26221900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bone marrow WT1 gene expression and clinical significance in chronic myelogenous leukemia].
    Cao XS; Gu WY; Chen ZX; Hu SY; He J; Cen JN
    Zhonghua Nei Ke Za Zhi; 2007 Apr; 46(4):277-9. PubMed ID: 17637262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of minimal residual disease by quantitative WT1 gene expression following reduced intensity conditioning allogeneic stem cell transplantation in acute myeloid leukemia.
    Candoni A; Toffoletti E; Gallina R; Simeone E; Chiozzotto M; Volpetti S; Fanin R
    Clin Transplant; 2011; 25(2):308-16. PubMed ID: 20412098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up of minimal residual disease in acute childhood lymphoblastic leukemia by WT1 gene expression in the peripheral blood: the Hungarian experience.
    Magyarosy E; Varga N; Timár J; Rásó E
    Pediatr Hematol Oncol; 2003; 20(1):65-74. PubMed ID: 12687755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia.
    Ogawa H; Tamaki H; Ikegame K; Soma T; Kawakami M; Tsuboi A; Kim EH; Hosen N; Murakami M; Fujioka T; Masuda T; Taniguchi Y; Nishida S; Oji Y; Oka Y; Sugiyama H
    Blood; 2003 Mar; 101(5):1698-704. PubMed ID: 12406915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fluorescence quantitative PCR detection of WT1 gene expression in peripheral blood of patients with acute leukemias and its clinical implications].
    Bai B; Wang HW; Xu YQ; Yang HN; Qiao ZH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):610-4. PubMed ID: 16129044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WT1 mRNA level in peripheral blood is a sensitive biomarker for monitoring minimal residual disease in acute myeloid leukemia.
    Sakamoto Y; Mariya Y; Sasaki S; Teshiromori R; Oshikiri T; Segawa M; Ogura K; Akagi T; Kubo K; Kaimori M; Funato T
    Tohoku J Exp Med; 2009 Oct; 219(2):169-76. PubMed ID: 19776535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescent 5'-exonuclease assay for the absolute quantification of Wilms' tumour gene (WT1) mRNA: implications for monitoring human leukaemias.
    Kreuzer KA; Saborowski A; Lupberger J; Appelt C; Na IK; le Coutre P; Schmidt CA
    Br J Haematol; 2001 Aug; 114(2):313-8. PubMed ID: 11529849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation between clinical outcome and WT1 detection after hematopoietic stem cell transplantation in acute leukemia].
    Zhao BR; Tang XW; Cen JN; Jin S; Shi XL; Wei XA; Chang WR; Sun AN; Wu DP
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(20):1375-8. PubMed ID: 21756806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurable residual disease monitoring using Wilms tumor gene 1 expression in childhood acute myeloid leukemia based on child-specific reference values.
    Løvvik Juul-Dam K; Guldborg Nyvold C; Vålerhaugen H; Zeller B; Lausen B; Hasle H; Beier Ommen H
    Pediatr Blood Cancer; 2019 Jun; 66(6):e27671. PubMed ID: 30900388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.
    Menssen HD; Renkl HJ; Rodeck U; Maurer J; Notter M; Schwartz S; Reinhardt R; Thiel E
    Leukemia; 1995 Jun; 9(6):1060-7. PubMed ID: 7596170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.